Delivery Order SPE2DB22D9205-SPE2DB24FZF76
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $1,892.90. The order is for the supply of 4562879115 NUCALA 100 MG/ML auto-injectors to fulfill requirements at Defense Logistics Agency Troop Support Medical facilities. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million through December 2025, to provide...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $7,571.60 by the Defense Logistics Agency Troop Support Medical to provide NUCALA 100 MG/ML auto-injectors. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolin...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency. The delivery order is for the supply of 4562675402 NUCALA 100 MG/ML auto-injectors to fulfill requirements at DLA Troop Support Medical facilities. As a woman-owned small business, DMS Pharmaceutical Group provides a wide range of pharmaceutical and medical products in support of the Defense Logistics Agency's global operations....
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $5,678.70 by the Defense Logistics Agency Troop Support Medical to provide NUCALA 100 MG/ML auto-injectors. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolin...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $22,714.80 by the Defense Logistics Agency Troop Support Medical to provide NUCALA 100 MG/ML auto-injectors. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, midazolin...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at three thousand seven hundred eighty-five dollars and eighty cents ($3,785.80) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against an indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at five thousand six hundred seventy-eight dollars and seventy cents ($5,678.70) by the Defense Logistics Agency Troop Support Medical. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS Pharmaceutical Group will...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand eight hundred ninety-two dollars and ninety cents ($1,892.90) by the Defense Logistics Agency Troop Support Medical. The delivery order is for the supply of NUCALA 100 MG/ML auto-injectors to fulfill requirements through November 30, 2023. DMS Pharmaceutical Group Inc. will provide the pharmaceutical items under an existing indefinite delivery contract with the Defense Logistics Agency,...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100MG/ML 1ML 1S. The delivery order has no set-aside designation and performance is to be completed by December 15, 2023. As a woman-owned small business and woman-owned business, DMS Pharmaceutical Group holds this pharmaceutical prime vendor contract vehicle with the Defense Logistics Agency to directly supply...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand three hundred fifty-seven dollars and forty cents ($11,357.40) by the Defense Logistics Agency Troop Support Medical. The delivery order is for the supply of 4562879717 NUCALA 100 MG/ML auto-injectors to fulfill requirements through November 2023. DMS Pharmaceutical Group is a woman-owned small business and woman-owned business pharmaceutical wholesaler that currently holds an indefinite...
- SPE2DB22D9205Indefinite Delivery Contract
- SPE2DB22D9205-SPE2DB24FZF76Delivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency for $5,678.70. The order is for the supply of NUCALA 100 MG/ML auto-injectors to fulfill requirements at Defense Logistics Agency Troop Support Medical facilities. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, valued at up to $5 million through December 2025, to provide pharmaceuticals and medical supplies including atropine, Surgilube lubricant, heparin, Narcan nasal spray, intravenous saline, and midazolam hydrochloride. As a woman-owned small business, DMS Pharmaceutical Group has extensive experience servicing Defense Logistics Agency medical treatment facilities through delivery orders issued against various contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 12/1/23 |